Humanetics Secures DoD Grant for Anti-Radiation Drug Development
Humanetics has received a $3.8 million grant from the Defense Department to produce solid dosage forms of a drug currently in clinical development as a medical countermeasure for lethal toxicities related to radiation exposure. Th company said Tuesday it will further develop the BIO 300 drug for potential use by soldiers and first responders at high risk […] More